Also, we must evaluate whether or not the serial change of serum HO-1 could reflect disease progression from the initial stage of infection to DAD, though we previously reported on a case of AE of IPF that was triggered by COVID-19 in which continuous HO-1 measurements could be clinically useful in tracking severity and predicting disease prognosis [51]. The gene discussed is HMOX1; the disease is COVID-19.